Acucela DRC A Phase 2a Multicenter, Randomized, Masked Study Evaluating the Pharmacodynamics of Emixustat Hydrochloride in Subjects with Macular Atrophy Secondary to Stargardt Disease
Research Grant
Awarded By
Acucela Inc.
Start Date
December 6, 2016
End Date
May 9, 2018
Awarded By
Acucela Inc.
Start Date
December 6, 2016
End Date
May 9, 2018